食管恶性肿瘤术后吻合口良性狭窄首次扩张最佳直径探讨
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Exploration of the optimal diameter for the first dilation of mild to moderate benign anastomotic stenosis after esophageal cancer surgery
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨食管恶性肿瘤根治术后吻合口轻中度良性狭窄首次扩张的最佳直径。方法 回顾性分析 2015年1月-2022年6月我院83例行食管恶性肿瘤根治术后吻合口良性狭窄患者的临床资料,根据首次内镜下球囊扩张直径分为12 mm组(n=21)、13.5 mm组(n=22)和16 mm组(n=40)。比较3组治疗的安全性、有效性及预后。结果 12、13.5和16 mm组扩张成功率分别为81.0%、90.9%和92.5%、并发症发生率分别为4.8%、4.5%和5.0%,差异均无统计学意义(均P>0.05)。12、13.5和16 mm组1年再狭窄率分别为94.1%、95.0%和67.6%,16 mm组与12 mm组以及13.5 mm组相比,其12个月再狭窄率显著下降(P=0.034,P=0.019)。12 mm组的中位狭窄复发时间为2(1.00, 3.00)月,13.5 mm 组的中位狭窄复发时间为 3.5(1.00, 5.25)月,16 mm组的中位狭窄复发时间为6.5(1.50, 12.00)月,16 mm组患者较12 mm组及13.5m m组患者狭窄复发时间明显缩短(均P<0.05);12、13.5和16 mm组扩张后1年中位再扩张次数分别为3(2.00, 4.00)、2 (1.75, 3.25) 和2(0.00, 2.00)次,16 mm组较12 mm组和13.5 mm组扩张次数明显减少(均P<0.05);12 mm组与13.5 mm组1年再狭窄、狭窄复发时间、1年内再扩张次数相比差异均无统计学意义(P> 0.05)。扩张前直径<5 mm、首次扩张后吻合口直径<15 mm、首次扩张距离手术时间≥3个月,是扩张后1年内再狭窄的危险因素(OR>1,P<0.05)。结论 对于食管恶性肿瘤根治术后吻合口轻中度良性狭窄,首次内镜下扩张至16 mm为最佳扩张直径

    Abstract:

    Objective To explore the optimal diameter for the first dilation of mild to moderate benign stenosis of the anastomotic site after radical resection of esophageal malignant tumors. Methods A retrospective analysis was conducted on the clinical data of 83 patients with benign anastomotic stenosis after radical resection of esophageal malignant tumors from January 2015 to June 2022. According to the diameter of the first endoscopic balloon dilation, they were divided into 12mm, 13.5mm, and 16mm groups. The safety, effectiveness, and prognosis of the three treatment groups were compared.Results The success rates of expansion in the three groups were 81.0%, 90.9%, and 92.5%, respectively, and the incidence of complications was 4.8%, 4.5%, and 5.0%, respectively, with no statistically significant difference (P=0.369; P=0.999). The 12 month restenosis rates were 94.1%, 95.0%, and 67.6%, respectively. Compared with the 12mm and 13.5mm groups, the 16mm group had a significant decrease in the 12 month restenosis rate (P=0.034, P=0.019). The median recurrence time of stenosis in the 12mm group was 2 (1.00, 3.00) months, the median recurrence time of stenosis in the 13.5mm group was 3.5 (1.00, 5.25) months, and the median recurrence time of stenosis in the 16mm group was 6.5 (1.50, 12.00) months. The recurrence time of stenosis in the 16mm group was significantly shorter than that in the 12mm and 13.5mm groups (P=0.026, P=0.048), and the median number of redilations in the three groups after dilation was 3 (2.00, 4.00), 2 (1.75, 3.25), and 2 (0.00, 2.00) times, respectively. The expansion frequency of the 16mm group was significantly reduced compared to the 12mm and 13.5mm groups (P=0.003, P=0.032)However, there was no significant difference between the 12mm group and the 13.5mm group (P>0.05). A diameter of<5mm before dilation, a diameter of<15mm after initial dilation, and a distance of ≥ 3 months from initial dilation to surgery are risk factors for restenosis within one year after dilation (OR>1, P<0.05).Conclusion For mild to moderate benign stenosis of the anastomotic site after radical resection of esophageal malignant tumors, the optimal diameter for initial endoscopic dilation is 16mm

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-12-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司